Novartis also counts AI partnerships with other tech companies like Amazon for augmenting supply chain visibility and Alphabet's life sciences arm Verily for faster participant recruitment—highlighting that pharma companies have a vast range of needs that can be filled by different vendors.
Alphabet subsidiary Verily is working on a pilot project to help people in the San Francisco Bay Area understand whether they should seek a COVID-19 test. And plenty of more traditional brands have a role to play in easing the crisis.
Alphabet—through its health-focused subsidiary Verily—recently developed technology that uses retinal scans and AI algorithms to detect age, blood pressure and smoker status, which can be used to predict whether someone is at risk for a heart attack.
As facial recognition systems become increasingly accurate, more governments and law enforcement organizations are tapping them to verify people’s identities, nab criminals and keep transactions secure.